| Primary |
| Hypertension |
42.9% |
| Arthropathy |
7.1% |
| Product Used For Unknown Indication |
7.1% |
| Rheumatoid Arthritis |
7.1% |
| Atrial Fibrillation |
3.6% |
| Cardiac Failure |
3.6% |
| Dyslipidaemia |
3.6% |
| Essential Hypertension |
3.6% |
| Hepatic Cirrhosis |
3.6% |
| Metabolic Disorder |
3.6% |
| Pain |
3.6% |
| Prophylaxis |
3.6% |
| Respiratory Disorder |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
|
| Death |
20.7% |
| Anaemia |
6.9% |
| Guillain-barre Syndrome |
6.9% |
| Olfactory Nerve Disorder |
6.9% |
| Sensory Loss |
6.9% |
| Anaphylactic Shock |
3.4% |
| Dementia |
3.4% |
| Feeling Abnormal |
3.4% |
| Gynaecomastia |
3.4% |
| Hyponatraemia |
3.4% |
| Intervertebral Disc Protrusion |
3.4% |
| Lactose Intolerance |
3.4% |
| Normochromic Normocytic Anaemia |
3.4% |
| Polymyositis |
3.4% |
| Presyncope |
3.4% |
| Proctalgia |
3.4% |
| Renal Failure Acute |
3.4% |
| Skin Exfoliation |
3.4% |
| Somnolence |
3.4% |
| Spider Vein |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
58.0% |
| Cerebrovascular Disorder |
8.7% |
| Hypertension |
5.8% |
| Diabetes Mellitus |
4.3% |
| Essential Hypertension |
4.3% |
| Osteoporosis |
2.9% |
| Addison's Disease |
1.4% |
| Anxiety |
1.4% |
| Cerebrovascular Accident |
1.4% |
| Dementia Alzheimer's Type |
1.4% |
| Depression |
1.4% |
| Gastritis Prophylaxis |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Insomnia |
1.4% |
| Localised Infection |
1.4% |
| Mania |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
|
| Tubulointerstitial Nephritis |
17.6% |
| Fall |
11.8% |
| Hyponatraemia |
11.8% |
| Organising Pneumonia |
11.8% |
| Azoospermia |
5.9% |
| Hypotension |
5.9% |
| Somnolence |
5.9% |
| Troponin Increased |
5.9% |
| Troponin T Increased |
5.9% |
| Upper Limb Fracture |
5.9% |
| Vomiting |
5.9% |
| Weight Increased |
5.9% |
|
| Concomitant |
| Hypertension |
24.6% |
| Drug Use For Unknown Indication |
20.4% |
| Product Used For Unknown Indication |
16.2% |
| Rheumatoid Arthritis |
6.8% |
| Diabetes Mellitus |
5.0% |
| Prophylaxis |
4.2% |
| Type 2 Diabetes Mellitus |
3.6% |
| Pain |
2.5% |
| Atrial Fibrillation |
1.6% |
| Colorectal Cancer |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Asthma |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Osteoporosis |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Bronchitis |
1.3% |
| Chronic Hepatitis C |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Colorectal Cancer Metastatic |
1.3% |
| Coronary Artery Disease |
1.3% |
|
| Myocardial Infarction |
10.5% |
| Renal Failure Acute |
10.5% |
| Vomiting |
9.3% |
| Coeliac Disease |
7.0% |
| Transaminases Increased |
5.8% |
| Mouth Ulceration |
4.7% |
| Pulmonary Embolism |
4.7% |
| Rash Generalised |
4.7% |
| Vision Blurred |
4.7% |
| Atrial Fibrillation |
3.5% |
| Cardiac Failure |
3.5% |
| Eyelid Oedema |
3.5% |
| Haemorrhage |
3.5% |
| Hepatic Failure |
3.5% |
| Hepatitis |
3.5% |
| Regurgitation |
3.5% |
| Respiratory Depression |
3.5% |
| Sepsis |
3.5% |
| Skin Exfoliation |
3.5% |
| Somnolence |
3.5% |
|
| Interacting |
| Hypertension |
26.3% |
| Coronary Artery Disease |
21.1% |
| Cardiac Failure |
10.5% |
| Hepatic Cirrhosis |
10.5% |
| Type 2 Diabetes Mellitus |
10.5% |
| Atrial Fibrillation |
5.3% |
| Dyslipidaemia |
5.3% |
| Dyslipidemia |
5.3% |
| Hyperlipidaemia |
5.3% |
|
| Ventricular Extrasystoles |
50.0% |
| Drug Interaction |
25.0% |
| Renal Impairment |
25.0% |
|
